Indication

For treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.

Medicine details

Medicine name:
relugolix/estradiol/norethisterone acetate (Ryeqo)
SMC ID:
SMC2442
Pharmaceutical company
Gedeon Richter UK Ltd
BNF chapter
Obstetrics, gynaecology, and urinary-tract disorders
Submission type
Full
Publication due date:
13 June 2022
Patient group submission deadline:
04 April 2022